These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 27725639)

  • 1. Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations.
    Tosoian JJ; Gorin MA; Ross AE; Pienta KJ; Tran PT; Schaeffer EM
    Nat Rev Urol; 2017 Jan; 14(1):15-25. PubMed ID: 27725639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.
    Kim J; Park JS; Ham WS
    Investig Clin Urol; 2017 Sep; 58(5):307-316. PubMed ID: 28868501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review.
    Koo KC; Dasgupta P
    Yonsei Med J; 2018 Jul; 59(5):567-579. PubMed ID: 29869454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical Prostatectomy for Patients With Oligometastatic Prostate Cancer.
    Ahmad AE; Leão R; Hamilton RJ
    Oncology (Williston Park); 2017 Nov; 31(11):794-802. PubMed ID: 29179248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligometastatic Prostate Cancer.
    Navrátil J; Poprach A; Lakomý R; Kocák I; Vašina J; Krupa P; Vyzula R
    Klin Onkol; 2019; 32(2):97-100. PubMed ID: 30995848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?
    Slaoui A; Albisinni S; Aoun F; Assenmacher G; Al Hajj Obeid W; Diamand R; Regragui S; Touzani A; Bakar A; Mesfioui A; Karmouni T; Ameur A; Elkhader K; Koutani A; Ibnattya A; Roumeguere T; Peltier A
    World J Urol; 2019 Nov; 37(11):2343-2353. PubMed ID: 30706122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease.
    Larbi A; Dallaudière B; Pasoglou V; Padhani A; Michoux N; Vande Berg BC; Tombal B; Lecouvet FE
    Prostate; 2016 Aug; 76(11):1024-33. PubMed ID: 27197649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Local Therapy for Oligometastatic Prostate Cancer: Should We Expect a Cure?
    Nair R; Lamb BW; Geurts N; Alghazo O; Lam W; Lawrentschuk N; Murphy DG
    Urol Clin North Am; 2017 Nov; 44(4):623-633. PubMed ID: 29107278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment of local disease in metastatic prostate cancer.].
    Gaya JM; Huguet J; Breda A; Palou J
    Arch Esp Urol; 2018 Mar; 71(3):288-297. PubMed ID: 29633950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [When is surgical treatment indicated in metastatic prostate cancer and what is the scientific rationale?].
    Kretschmer A; Herlemann A; Stief CG; Gratzke C
    Urologe A; 2017 May; 56(5):599-603. PubMed ID: 28314971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up.
    Gandaglia G; Fossati N; Stabile A; Bandini M; Rigatti P; Montorsi F; Briganti A
    Eur Urol; 2017 Aug; 72(2):289-292. PubMed ID: 27574820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the treatment of oligometastatic prostate cancer].
    Li WJ; Mo RY; Li XJ
    Zhonghua Nan Ke Xue; 2020 Sep; 26(9):832-837. PubMed ID: 33377709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Is Oligometastatic Prostate Cancer?
    Fraser M; Koontz B; Emmenegger U; De Meerleer G; Khoo V; Feng F; Corcoran NM; Hovens CM; Tran PT; Ost P; Boutros PC;
    Eur Urol Focus; 2019 Mar; 5(2):159-161. PubMed ID: 30642810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in oligometastatic prostate cancer: Is there a role for radical prostatectomy?
    Marenco J; Sooriakumaran P
    Arch Esp Urol; 2019 Mar; 72(2):174-181. PubMed ID: 30855019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oligometastatic prostate cancer. concept and implications.].
    Carrasco Valiente J; Ruiz García JM; Requena Tapia MJ
    Arch Esp Urol; 2018 Mar; 71(3):239-246. PubMed ID: 29633944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligometastatic prostate cancer: The game is afoot.
    Lancia A; Zilli T; Achard V; Dirix P; Everaerts W; Gomez-Iturriaga A; Ingrosso G; Liefhooghe N; Miralbell R; Siva S; Van der Eecken K; Ost P
    Cancer Treat Rev; 2019 Feb; 73():84-90. PubMed ID: 30684842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature.
    Ost P; Bossi A; Decaestecker K; De Meerleer G; Giannarini G; Karnes RJ; Roach M; Briganti A
    Eur Urol; 2015 May; 67(5):852-63. PubMed ID: 25240974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of positive lymph nodes following radical prostatectomy.
    Heidenreich A; Rieke M; Mahjoub S; Pfister D
    Arch Esp Urol; 2019 Mar; 72(2):182-191. PubMed ID: 30855020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligometastatic prostate cancer: shaping the definition with molecular imaging and an improved understanding of tumor biology.
    Joice GA; Rowe SP; Pienta KJ; Gorin MA
    Curr Opin Urol; 2017 Nov; 27(6):533-541. PubMed ID: 28863016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.